Promising Is Not the Same as Proven
A supplement may improve a biological marker in laboratory experiments. A medication may extend lifespan in mice. A new treatment may produce encouraging results in a small group of people.
But how do we know whether it actually works?
Clinical trials are designed to test interventions in humans.
They are especially important in longevity medicine, where promising discoveries sometimes reach the public long before their clinical benefits have been established.
What Is a Clinical Trial?
A clinical trial is a research study in which participants receive an intervention according to a research plan.
The intervention might be a medication, supplement, exercise program, dietary strategy or medical procedure.
Researchers assess its effects on predefined outcomes.
These might include blood pressure, physical performance, disease incidence or quality of life.
For longevity interventions, it is particularly important to distinguish changes in laboratory biomarkers from meaningful improvements in health.
Why Are Randomized Trials Important?
In a randomized controlled trial, participants are assigned by chance to different study groups.
One group may receive the intervention being tested, while another receives a comparison intervention or usual care.
Random assignment helps make the groups comparable at the beginning of the study.
This reduces the possibility that differences in age, health or lifestyle explain the results.
Randomization is one of the strongest methods available for testing whether an intervention causes a particular effect.
However, randomization alone does not guarantee that a trial is reliable.
What Is a Control Group?
A control group provides a comparison.
Without one, improvements observed during a study might be incorrectly attributed to the treatment.
For example, participants may improve because of natural recovery, changes in lifestyle or additional medical attention.
A comparison group helps researchers determine whether the intervention itself makes a difference.
The comparison may involve usual care, another treatment or a placebo.
What Is a Placebo?
A placebo is a treatment or substance designed to resemble the intervention being tested without containing its specific active component.
Placebos help researchers account for expectations and other influences on reported outcomes.
They are particularly useful when outcomes include symptoms, pain or perceived well-being.
However, placebo use is not appropriate in every situation. Established effective treatment should not be withheld when doing so would expose participants to unacceptable harm.
What Do Single-Blind and Double-Blind Mean?
Blinding, also called masking, means keeping certain people unaware of which treatment a participant receives.
This helps reduce the influence of expectations on the results.
Clinical trials may use different approaches:
* Open-label: Participants and researchers know which treatment is being given. * Single-blind: One group, usually the participants, does not know which treatment is being received. * Double-blind: Participants and the researchers involved in treatment or assessment are kept unaware of treatment assignments.
In practice, the precise meaning of single-blind and double-blind can vary between studies. Researchers should therefore specify exactly who was blinded.
Double-blind trials are particularly valuable when expectations could influence symptoms or assessments.
Some interventions, such as exercise programs, are difficult to conceal from participants. These trials can still provide reliable evidence when carefully designed.
What Are the Phases of Clinical Trials?
For new medicines, clinical development is commonly divided into phases.
Phase 1 primarily investigates safety, tolerability and how a treatment behaves in the body.
Phase 2 explores potential effectiveness and continues evaluating safety.
Phase 3 usually involves larger studies intended to confirm benefits and assess adverse effects.
Phase 4 examines treatments after approval, including longer-term safety and real-world use.
Not every lifestyle intervention follows this pharmaceutical development structure.
Why Do Longevity Trials Face Special Challenges?
Aging develops over decades.
A trial lasting several months may detect changes in cholesterol, inflammation or a biological-age marker, but it cannot necessarily establish that participants will live longer or remain healthier.
Researchers may therefore use intermediate outcomes.
These can be informative, but they should not automatically be treated as proof of extended lifespan.
A promising result in animals also needs appropriate confirmation in humans.
What Should You Look For?
When reading about a new longevity intervention, consider whether the study included a comparison group, randomized participants and measured outcomes relevant to health.
Also examine the number of participants, duration of follow-up and reported adverse effects.
A treatment should not be considered effective simply because it is new, biologically interesting or supported by a small preliminary trial.
Based on Research
Higgins JPT, Savović J, Page MJ, et al. Assessing Risk of Bias in a Randomized Trial. In: Cochrane Handbook for Systematic Reviews of Interventions, version 6.5, 2024. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-08
National Library of Medicine. ClinicalTrials.gov Glossary. Definitions of randomized trials, masking, placebo and clinical trial phases. https://clinicaltrials.gov/glossary
